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Since the establishment ofthe National Toxicology Program (NTP), there have been gradual changes in
strategiestoevaluate theoveralltoxicityofchemicals aswell astheircarcinogenic potential. The spectrum
of toxicologic information sought on selected chemicals has been broadened by the multidisciplinary
approach toevaluating chemicals. This paperdescribes the scientific rationale and experimental processes
used by NTP in designing studies. Also, an outline ofcurrent NTP protocols are given for prechronic and
chronic toxicitv/carcinorenicitv studies.
Introduction
The National Toxicology Program (NTP) was estab-
lished in November 1978 by the Secretary of the De-
partment of Health and Human Services (DHHS). The
primary rationale was to betterintegrate DHHS activi-
ties and resources concerned with determining the toxi-
cologic potential of chemicals and to establish a more
effectivedialoguebetweenthehealthresearchand regu-
latory agencies, enabling stronger links between the
health research and regulatory needs. Four specific
goalsofNTPcontinuetobroadenthespectrumoftoxico-
logic information obtained on chemicals selected; in-
crease the number of chemicals evaluated within re-
source limits; develop and validate aseries ofassays and
protocols appropriate forregulatory needs; and commu-
nicate the plans and results to governmental agencies,
the medical and scientific communities, and the public
(1).
Since the establishment ofthe NTP, there have been
gradual changes in strategies to evaluate the toxicity
andcarcinogenic potential ofchemicals. The spectrumof
toxicologicinformation sought onselected chemicals has
been broadened by the multidisciplinary approach to
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evaluatechemicals. Theexpertiseingeneraltoxicology,
genetics, reproduction, pathology, chemistry, clinical
pathology, animal care, immunology, statistics, andbio-
chemicalandmoleculartoxicologyeachplayamajorrole
inidentifyingtoxicandcarcinogenicpropertiesofchemi-
cals. A number of communications representing NTP
efforts in meeting its goals have appeared in the litera-
ture (2-16).
The objectives of this paper are to present an over-
view of the scientific rationale involved in designing
toxicology and carcinogenesis studies and to outline the
experimental protocols used by the NTP in conducting
these studies. The studies designed by the NTP are
planned to provide maximal toxicology information on
chemicals selected.
Toxicological Evaluation Process
Figure 1 diagrams the general sequence of events
fromchemicalselectiontotoxicologicalcharacterization.
Once a chemical is identified as an NTP priority chemi-
cal, the process of designing studies begins. The
methods established and announced widely by the NTP
for nominating, selecting, and designing studies give
ample opportunity to industry, nominating/regulatory
agencies, andthepublictoinfluencethefinal outcomeof
study designs (1). This process has resulted in develop-
ing studies and protocols that are used to advance the
science and for regulatory purposes as well as develop-
ing a toxicity data base on chemicals. In general, theseCHHABRA ET AL.
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FIGURE 1. Toxicological evaluation process,
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National Toxicology
studies are accomplished in two phases: prechronic or
short-term studies and chronic or longer-term toxicity/
carcinogenicity studies. Because ofstaffand laboratory
space limitations these studies are ordinarily conducted
at private laboratories and at national laboratories that
have been approved by the NTP to perform such stud-
ies. The prechronic studies usually consist ofthose last-
ing 14 days and 90 days. Because few laboratories can
perform studies in all disciplines, genetic toxicology,
metabolism/disposition, immunotoxicology, and
reproductive/developmental toxicology studies are con-
ductedindifferentlaboratories that areexperienced and
specialized in these areas. To the maximum extent pos-
sible data obtained from these labs, along with the
prechronic toxicology data, are available in designing
and interpreting the chronic toxicity/carcinogenicity
studies.
After the 14-day and 90-day studies are completed,
scientificdecisions are made onwhether ornot achronic
studyisrequired on achemical. Someofthecriteriaused
to justify a chronic toxicity/carcinogenicity study for a
chemical are as follows: production for a chemical and
human exposure levels, epidemiology studies indicative
ofthe association ofchemicals with increased incidence
of cancer in human population, results of a prechronic
toxicity study showing nonneoplastic lesions that could
progress to neoplastic lesions during chronic exposure,
chemicals that are structurally related to carcinogens,
and aneedforsuchstudiesbythenominating/regulatory
agencies. Currently, nearly 50% of prechronic studies
are followed by 2-year chronic toxicity/carcinogenicity
studies.
General Considerations for
Designing Studies
The NTP evaluates a large variety of chemicals for
toxicity/carcinogenicity. The chemicals may be used in
agriculture, manufacturing and pharmaceutical indus-
tries, orthey maybe food additives or occur as environ-
mentalcontaminants. Designingstudiesforsuchdiverse
classes of chemicals requires a flexible approach and
avoidance of rigid generic protocols. The NTP has
adopted corestudyprotocolsintermsofspecies, strains,
group size, and number ofdose groups, and duration of
exposure for prechronic and chronic studies. However,
the toxicity end points studied for chemicals evaluated
depend on anumberoffactorssuch as usepatternsofthe
chemical, anticipated biological effects based on struc-
turalsimilaritytoknownclassesofchemicals, andmech-
anism(s) of toxicity of chemicals in the same general
class. Following are some of the major scientific and
practical considerations in designingtoxicology studies.
Background Information
A thorough knowledge is essential for background
information on the chemicals selected for toxicity/carci-
nogenicityevaluation. Toaccomplishthisthestudytoxi-
cologistevaluatesallinformationintheliterature, inter-
acts with the individual or agency nominator(s), and
consultswithmanufacturer(s) ofthechemicaland repre-
sentative regulatory agencies and other scientists. This
background information generally includes physical and
chemical properties of the chemical, production levels,
human exposure data, results from previously con-
ducted mutagenicity and short-term tests, metabolism/
pharmacokinetics studies, teratogenicity, and repro-
ductive toxicity studies. Background material also in-
cludes known information relative to carcinogenicity,
epidemiology, mechanism of toxicity, neurobehavioral
toxicity, immunotoxicity, and other target-organ toxic-
ity. Based on the extent and adequacy ofthis informa-
tion, strategies are developed for evaluating chemical
toxicity/carcinogenicity, and important areas oftoxicol-
ogy needing more work are identified. Significant por-
tionsofthestudydesignreflect anefforttofillthesedata
gapswhenapprobriate. Table 1 givestheinformation on
studies designed for 98 chemicals as an example ofthis
effort.
Wheneverpossible, duringthe conduct of90-day tox-
icity studies and where appropriate, genetic toxicity,
metabolism/disposition, hematology, and reproductive/
Table 1. Types of studies designed on 98 nominated and selected
chemicals.
Study Number
14-day studies 69
90-day studies 75
Genetic toxicology 78
Metabolism/disppsition 26
Immunotoxicology 13
Reproductive/developmental toxicity 24
Chronic toxicity/carcinogenicity 39
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developmental toxicity studies are performed in paral-
lel. Researchers should have results from these studies
availablebeforechronicstudies aredesigned. Thetoxic-
ity end points incorporated in 90-day studies are deter-
mined on a case-by-case basis for individual chemicals;
Table2showsthefrequencyoftoxicityendpointsincor-
porated into 75 recent 90-day studies. This table shows
that selection of toxicity end points depends on the
background information available on a particular
chemical.
Table 3 gives key features of study design for 39
chemicals, furtheremphasizingthe approachto evaluat-
ing chemical toxicity/carcinogenicity based on deter-
mining what additional information is needed for a
chemical to best fill data gaps and, importantly, to best
protect public health. The carcinogenicity studies gen-
erally consist of three exposure groups plus a control.
These four groups are used to better define the dose
responserelationship thataidsinthe hazard assessment
of chemicals having carcinogenic potential in humans
(17,18). Each dose group consists of a minimum of 50
animalsperspecies/sex, whichisconsideredoptimumby
the International Agency for Research on Cancer
(IARC) (19) and most others involved in these studies.
Theadequacy ofgroupsizeforcarcinogenicity studies
hasalsobeendealtwithinthereportbythe NTPAdHoc
Panel (20). Each ofthe 39 NTP carcinogenicity studies
Table 2. Some features of 90-day studies.
Feature Number
Sperm morphology and vaginal cytology 61
Hematology 58
Clinical pathology 61
Micronuclei in mouse erythrocytes 40
Urinalysis 29
Biochemical indices 21
Neurobehavioral evaluations 6
Routes ofexposure
Feed 30
Inhalation 21
Drinking water 6
Dermal 4
Gavage 3
Intraperitoneal 1
Comparison of routes (more than one route) 10
Table 3. Some features of 39 two-year toxicity/carcinogenicity
studies.
Two-year studies at least have three dose levels plus controls
Three of these 39 studies were designed with more than three dose
groups
All studies had additional groups from animals to be evaluated for
toxicity and possible carcinogenicity at week 65
Fifteen studies had two or more interim evaluations
Seven studies had stop exposure studies
All designed for both sexes of two rodent species
All performed under extended good laboratory practices
All performed under strict health and safety standards
Routes ofexposure
Feed, 12 studies
Gavage, 9 studies
Drinking water, 7 studies
Inhalation, 10 studies
Dermal, 1 study
designed had at least one interim evaluation group of10
animals/sex at week 65. The purpsoe ofinterim evalu-
ationistoidentifychronictoxiceffectsofthechemicalas
well as any late appearingtoxic effects that may help in
changingthe courseofstudies, ifneeded. Insomecases,
neoplasia is observed. Currently NTP is reviewing the
useoftheweek65interimevaluationtodetermineifitis
usefultohaveeitheraroutineinterimevaluationortobe
selective in incorporating evaluation group(s) to carci-
nogenicity studies. Table 3 also shows that 15 studies
had two or more interim evaluations at different time
intervals. Again, the purpose was to establish relation-
ships between the time of exposure and possibility of
late-appearing lesions. Seven studies had chemical ex-
posure ofthe animals stopped (stop exposure) at a spe-
cific time interval during the studies; regression/
progression of specific lesions was followed up to the
termination of experiment (2 years). Usually these le-
sions are first identified during 90-day studies.
Multidisciplinary Approach
Input from several scientific disciplines (e.g., toxicol-
ogy, chemical disposition, immunotoxicity, pathology,
genetic toxicology, laboratory animal management,
chemistry, health and safety, statistics, etc.) is incor-
poratedintothe studydesign. Theusefulness oftoxicol-
ogy procedures are critically reviewed by the various
disciplines before they are incorporated into study de-
signs. The toxicology procedures are continuously im-
proved and validated by the NTP and contract labora-
tories. Recent publications on the development of a
battery ofassays for assessing chemical-induced immu-
notoxicity (15) and measurement ofbehavior indices of
neurotoxicityaresomeoftheexamplesforimprovement
ofprocedures (16,21).
Experimental Animals
The toxicology and carcinogenesis studies are con-
ducted in rats and mice. Fischer 344 rats and B6C3F1
(C57BL/6N x C3H/HENMTV-) mice are the selected
experimentalanimalsforcarcinogenesis studiesandwill
continue to be used for NTP prechronic and chronic
toxicity/carcinogenicity studies until data show that
other strains/species would be more relevant. The his-
toricalbackgroundonselectionoftheseanimalshasbeen
reviewed by Weisburger (22). Goodman et al. (23) have
reviewed in depth the advantages and disadvantages of
Fischer344 rats and B6C3F1 mice as compared to other
strains of rats and mice as experimental animals for
carcinogenesis studies. Their review suggests that, at
present, Fischer 344 rats and B6C3F1 mice should re-
mainastheexperimentalanimalsofchoiceforlong-term
studies. Inaddition, NTPhasthevaluableandextensive
historical control data base for these species.
An ad hoc panel on chemical carcinogenesis testing
andevaluationreviewed NTPtoxicityandcarcinogenic-
ity evaluation procedures (20). One ofthe recommenda-
tions of that panel was "if a determination is made to
maintain a two species bioassay protocol, give serious
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consideration toreplacement ofthe B6C3F1 mouse with
a strain having an established lower and less variable
spontaneous incidence of important tumors that are
induced by chemicals. In addition, continued inves-
tigation oftheuse ofotherspecies asadjunct orreplace-
ment for the one now in use should be undertaken." To
address the first part ofthe recommendation, the NTP
formed an ad hoc committee and organized a workshop
on Strains ofMice for Chemical Carcinogenicity Studies
(24). The participants in that workshop reached a con-
sensusto"continue tousethe B6C3F1 hybridbecauseof
the extensive experience and historical data base with
this strain." A better alternative species was not iden-
tified, andtheconsensuswasreachedthatathirdrodent
species orreplacement ofthe rat ormouse with another
rodent species should not be aroutine procedure. How-
ever, ifthedispositionofachemicalbyhamstersorother
rodents is more similar to humans than by the rat or
mouse, then that other strain/species should be used
either in addition or as a replacement.
NTPstudies aredesignedtoinsurethatthenumberof
animals used is as near to optimum as is scientifically
possible. Vigorous attempts are made to evaluate sev-
eral toxicity end points in the same set ofanimals. For
example, in90-daystudiesclinicalpathologyparameters
(enzymes, hematology), sperm motility and vaginal cy-
tologyevaluations(SMVCE), andhistopathologic evalu-
ations are carried out in the same group of animals.
Furthermore, no single exposure (acute) studies have
been undertaken for several years since data are often
available. Ifsufficient information is available to select
dose levels for 90-day studies, 14-day studies that
usually precede 90-day studies may not need to be per-
formed (Table 1).
Routes of Exposure
The awareness that human exposure to chemicals in
the environment cannot be reproduced exactly in ex-
perimental animals is well recognized; however, at-
tempts are made to expose animals under conditions as
closely as possible to human exposures. Table 2 shows
the different routes of exposure selected for seventy-
five 90-day studies. Ten studies were designed to com-
pare the toxicity of chemicals by two different routes.
For the remaining 65 designs, 39 were performed by
oral, 21 by whole body inhalation, 4 by dernal, and one
by the IP route ofexposure. Further breakdown ofthe
39 oral studies shows that dosed-feed was the most
preferred route of exposure (30 studies), followed by
drinking water (6 studies) and by gavage (3 studies).
Oral administration by gavage is used only if other
means of oral exposure are not feasible. This decision
was made because the oral intubation route is more
labor-intensive than other oral routes (feed, drinking
water). Alsoitdeliverschemicalasabolus(mostreason-
able for drugs and food additives), requires more direct
handling of animals by technicians that can result in
injurytotheanimals, andmayresultintissuedamage or
death.
Table 4. Criteria used for selection of routes of exposure.
Mode of chemical Major criteria used for selecing the mode
administration of exposure
Feed Major human exposure by oral route
Chemical is absorbed by all routes ofexposure
and optimum systemic exposure
Less labor-intensive
Drinking water Water-soluble, major human exposure through
drinking water
Gavage Chemicalreactive to oral mucous membrane by
other oral modes
Chemical unstable in feed or volatile
Chemical not palatable in diet
Difficult to make homogeneous in diet
Mimicks human exposure (drugs or food
additives)
Limited amount of chemical available
Containment of chemical needed to avoid
exposure to laboratory personnel and to the
environment
Dermal Major human exposure by skin
Skin as a target organ oftoxicity
Occupational exposure is primarily dermal
Two-stage initiation-promotion studies
Inhalation Major occupational exposure is by inhalation
(whole body) Pulmonary system is primary target system of
toxicity
Multiple routes Selected to mimic human exposure when more
than one route is common
Table 4 gives major criteria used for selection ofthe
most frequently used routes ofexposure. In addition to
the criteria listed in the table, the input from a regu-
latory agency may play amajorrole in selectingaroute
that helps in hazard risk assessment. NTP has begun
using microencapsulation ofchemicals as an alternative
means ofincorporating those chemicals into animal feed
when they can not be mixed easily orhomogeneously in
feed because of unpalatability, volatility, or reactivity
(25,26).
Chemical
In general, the chemicals selected for evaluation of
toxicity studies are representative of substances to
which the human population is exposed. In most in-
stances the materials used are commercial or technical
grades(27,28). However, therearesomeinstanceswhen
it is not practical to use commercial chemicals, which
include the following:
* Ifthe material being evaluated for toxicity is spar-
ingly soluble or not soluble in water or unstable in
the dosing mixture, the material can be used in its
saltformtoincreasesolubilityandpossiblystability.
* Whenanumberofstructurallyrelatedchemicalsare
evaluated to establish structure-activity relation-
ships, thepurestchemicalsavailableareselectedfor
toxicity/carcinogenicity studies.
* If the commercial grade of the material contains a
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contaminant that could confound the interpretation
ofthe results because ofits own toxicity, the pure
chemical is used to avoid possible interaction be-
tween the components; conversely, if the minor
component(s) of a commercial product are sus-
pected ofbeing responsible for the overall toxicity
ofthe product, then that contaminant in pure form
may be selected for toxicity evaluation.
Structure-Activity Relationships
One of the NTP criteria for chemical selection is the
understanding of structure-activity relationships
(SAR). This understanding thereby assists in defining
groups of chemicals that should be evaluated toxi-
cologically. The Interagency Testing Committee (ITC)
also uses structure-activity as one of the criteria for
selecting chemicals. SAR may be used to evaluate the
potential hazards ofchemicals that have not undergone
toxicity evaluation and alsohelpininterpretingtoxicity/
carcinogenicity data. Helmes et al. (29) reviewed the
SAR data in predicting potential carcinogenicity of
chemicals that have notundergone carcinogenicity eval-
uation. They have suggested that chemical structure
may be a predictor ofcarcinogenic activity ifthe infor-
mation available on the ultimate forms ofchemical car-
cinogens and the structural requirements for metabolic
activation. NTPisdeveloping adatabase on anumberof
structurallyrelated chemicals. Someoftheexamples are
benzidine dye congeners, dioxin/dibenzofurans, short
chain aliphatic hydrocarbons, aniline dyes, anthraqui-
nones, benzene and methyl benzene, dinitrolunenes,
phenylenediamines, toluene and dinitro toluenes.
Health and Safety Considerations
The design and activities of the health and safety
program are carried out toprotecttheworkershandling
chemicalsunderstudyandtosafeguardtheenvironment
by complying with regulations and guidelines for dis-
posingofchemicals and residuesbeingstudied (30). Itis
of the utmost importance that the health and safety
aspects of chemicals being evaluated are considered
early in the process, preferably at the time ofthe study
designs. In general, adequate methods are available or
can be developed to meet health and safety require-
ments. For inhalation studies where high flammability
of materials may be a concern, the maximum con-
centration used could necessitate extensive safety
precautions.
Selection of Dose Levels
The selection of dose levels especially for chronic
toxicity/carcinogenicity studies is atopicthatrequires a
separate and extensive review paper. Therefore, abrief
description ondose selectionisdiscussedhere. For more
details, the reader is referred to publications by Huffet
al., the NTP, and Haseman (14,20,31).
The selection ofdose levels for 90-day studies is gen-
erally based on the infonnation from preceding 14-day
toxicity studies; however, there may be a number of
instances whenthe doselevelsare selectedbased onthe
information available in the literature, and no 14-day
study is needed. Usually, the 90-day studies have five
dose groups and a control group. The highest exposure
group selected for studies is predicted to produce frank
toxicity, and the lowest dose is expected to produce no
adverse effects in the animals. The highest dose should
ideally produce no mortality. The lower dose levels are
generally spaced logrithmically using a factor of 2 or
simply halving the concentrations. It is expected that a
gradation of toxic responses will be observed at these
dose levels.
The highest dose selected forcarcinogenicity studies,
also termed the maximum tolerated dose (MTD), is
predicted to produce onlyminimalyet observable toxic-
ityintheanimals. Thetoxicityendpointsusedinselect-
ingthatdoselevelarelistedinTable5. Dependingonthe
toxicity end points used for an individual chemical dur-
ingprechronictoxicitystudies, oneorseveralendpoints
in combination may be used to select the highest dose.
The selection ofdose levels is essentially a professional
judgment; it is based on input from various specialities
and differs from chemical to chemical. However, the
basic philosophy of dose selection for carcinogenicity
studiesbythe NTPremainsessentiallythesame asthat
described by Sontag et al. (32). The major change has
beeninbroadening ofthe toxicology profilebythe NTP
in its 90-day studies, giving added confidence in esti-
matingthe dose levels selected, which accordingto NCI
guidelines "causes no more than a 10% weight de-
crement as compared to the appropriate control group;
anddoesnotproducemortality, clinicalsignsoftoxicity,
or pathologic lesions (other than those that may be
relatedtoaneoplasticresponse)thatwouldbepredicted
to shorten the animal's natural life span." The his-
topathologic and body weight changes have been major
parameters in estimation ofhigh dose. However, hema-
tology data for nitroaromatics, biochemical parameters
for organophosphate pesticides, hormonal levels for
chemicalscausingthyroidtoxicity, clinicalsignsoftoxic-
ity for central nervous system depressants or stimu-
lants, and behavioral and neurotoxicity parameters for
chemicals primarily affecting the nervous system are
some ofthe examples where these endpoints have been
majordeterminants oraidedintheselectionofhigh-dose
levels for carcinogenicity studies. Instances where cri-
teria other than toxicity parameters are considered in
selection of dose levels are listed in Table 6.
Table 5. Toxicity end points used in selecting dose levels for
chronic studies.
Body weights Hematology
Histopathologic changes Clinical chemistry
Mortality Metabolism/disposition
Clinical signs and toxicity Biochemical parameters
Pharmacologic signs Gross pathology
Food consumption and Organ weights
water consumption
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Table 6. Maximum dose levels established based on criteria
other than toxicity.
Route Criteria
Feed 5% maximum in diet in absence oftoxicity in
prechronic studies
Gavage 5 mL/kg in rats and 10 mL/kg in mice is the
maximum volume used for these studies;
solubility and suspendibility ofmaterial are
other limiting factors; usually stay below
1000 mg chemical/kg body weight
Dermal 0.1 mL for mice and 0.3 mL for rats is the
maximum volume applied
Inhalation Aerosol or particulate generation limits,
explosive limits, and lung burden levels
Drinking water Solubility, stability
The lower dose levels are usually one-half and one-
fourth ofthe highest dose level and generally not below
one-tenth ofhigh doselevel. Furtherinformation onthe
spread ofdose levels for carcinogenicity studies is dealt
with by Portier and Hoel (33) and Huff et al. (34).
Collaborative Efforts
Almost all of the prechronic and chronic studies are
performed at private laboratories. The capabilities of
these laboratories to perfonn specific toxicology ex-
periments is one ofthe considerations used in selecting
the laboratories. If a specific laboratory does not have
expertise in certain toxicology procedures, specific seg-
ments may be accomplished in other laboratories, or
such studies may be conducted in NTPlaboratory facili-
ties. For example, methyl isocyanate (MIC) studies
required a multidisciplinary approach and could not be
performed in a single laboratory. These studies were
performed largely in NTP laboratories.
Peer Review of Study Designs
All designs ofprechronic and chronic toxicity studies
are reviewed and approved by the NTP Toxicology
Design ReviewCommittee. Thiscommitteeiscomposed
of individuals within NTP having expertise in general
toxicology, reproduction, genetics, statistics, metabo-
lism/disposition, and pathology. On an ad hocbasis com-
mittee members represent other disciplines such as
clinical pathology, behavioral sciences, chemistry, ani-
mal care, health and safety, andimmunotoxicology. The
nominating, regulatory, andNTPparticipatingagencies
and representatives from industry are consulted on an
adhocbasisdepending ontheirinterest andexpertise in
an individual chemical.
Protocol Outlines of Prechronic and
Chronic Studies
The conduct ofprechronic and chronic toxicity/carci-
nogenicity studies are described in the official NTP
Statement ofWorkdocument. Thislarge document pre-
sents, inconsiderabledetail, the NTPrequirements and
procedures for performing toxicology studies. These
detailed guidelines are essential to the success ofdoing
our studies and, in particular, to be able to compare
results across studies done at various laboratories (35).
The following sections give an outline ofcore protocols
for 14-day and 90-day toxicity studies and 24-month
chronic toxicity/carcinogenicity studies, along with fre-
quent toxicity end points incorporated into study pro-
tocols. All of these studies are performed under Good
Laboratory Practices (36).
14-Day Toxicity Studies
The purpose of the 14-day studies is to characterize
thetoxicity associated with asubstanceadministered to
animals for 14 days. The objectives are to identify pos-
sible target organ(s), toxic effect similarities, and pos-
sible differences in sensitivity between sexes and
species and dose-response relationships of toxicity to
provide dose selection information for subsequent
studies.
Theusualprotocol(Table7)for14-daystudiesconsists
of six groups (five dose and one control) of animals of
each species and sex with five animals per dose group.
The control animals receive the vehicle in which the
substance is administered. The animals are observed
two times daily, at least 6 hrapart (before 10:00 AM and
2:00 PM), including holidays and weekends, for clinical
signs and pharmacologic and toxicologic effects, and
moribundity or death. Body weights and organ weights
(liver, thymus, right kidney, right testes, heart, brain,
and lungs, plus other organs as appropriate) are deter-
minedforallanimalssurvivinguntiltheendofthestudy.
A complete necropsy is performed on allexposed and
controlanimalsandalltissuesarepreservedinformalin.
If histopathological examination is required these tis-
sues are trimmed, embedded, sectioned, and stained
with hematoxylin and eosin, and evaluated.
90-Day Studies
The objective of90-day studies is to characterize the
toxicity associated with exposure over a period of
usually 13 weeks including identification of target or-
gan(s), lesions, similarities anddifferencesinsensitivity
between species and sexes, and the slope of dose-
response curve. These studies may be extended up to 6
months if it is considered that the expression of toxic
effects will take longer than 90 days or ifthe available
Table 7. 14-day studies.
Exposure
Parameter Animals Species Sex levels Totals
Exposure
group 5 2 2 5 100
Controls 5 2 2 1 20
Total 120
Exposure duration 14 days
Toxicity end points Mortality, clinical signs of toxicity, body
weights, food and water consumption, selected
organweights, grosspathology, histopathology
on selected organs.
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information suggests a carcinogenic effect may be ob-
served (e.g., benzidine dyes), Data from 90-day studies
are the primary information source used for selecting
dose levels for 2-year studies.
The core protocol (Table 8) for 90-day studies gen-
erally consists of five dosed groups plus one control
group, tenanimals/sex/species. Theanimalsareexposed
to the chemical for 13 consecutive weeks, after which
they are killed without any recovery period. The treat-
ment of animals, regimens for in-life observations,
necropsy, and organ weight are the same as for 14-day
studies. A complete histopathologic evaluation includes
approximately32tissues/organs (Table9)plussectionof
gross lesions, and it is conducted on all control animals,
all animals in the highest dose group with at least 60%
survival atthe end ofthe experiment, plusallanimals in
the highest dose group where death occurred. After
target organs of chemical toxicity are identified, these
tissue/organs plus gross lesions are examined his-
topathologically in lower doses until chemically induced
effects are no longer observable. A number of other
Table 8. 90-Day studies.
Exposure
Parameter Animals Species Sex levels Totals
Exposure
group 10 2 2 5 200
Controls 10 2 2 1 40
Total 240
Exposure duration 90 days
Toxicity end points Mortality, gross pathology, clinical signs oftox-
icity, histopathology, selected organ weights,
clinical pathology, hematology, sperm motility,
bodyweights, vaginalcytology evaluation, food
and water consumption, micronuclei in mice
Table 9. Tissues for histopathologic evaluation.
Gross lesions and tissue masses Heart
(and regional lymph nodes) Esophagus
Mandibular and mesenteric Stomach (forestomach and
lymph nodes glandular stomach)
Bronchial and mediastinal lymph Uterus
nodes (inhalation studies) Brain (three sections, including
Salivary gland frontal cortex and basal
Femur, including marrow ganglia, parietal cortex and
Thyroid gland thalamus, and cerebellum and
Parathyroid glands pons)
Small intestine (duodenum, Thymus gland
jejunum, ileum) Larynx (inhalation studies)
Large intestine (cecum, colon, Trachea
rectum) Pancreas
Liver Spleen
Gall bladder (mouse) Kidneys
Prostate Adrenal gland
Testes/epididymis/seminal Urinary bladder
vesicle Pituitary gland
Ovaries Spinal cord and sciatic nerve (if
Lungs and mainstem bronchi neurologic signs were present)
Nasal cavity and nasal Eyes (ifgrossly abnormal)
turbinates (three sections) Mammary gland
Preputial or clitoral glands Pharynx (ifgrossly abnormal)
Thigh muscle (13-week studies Skin
only)
toxicity end points such as immunotoxicology, chemical
disposition, behavioral toxicology, reproductive toxic-
ity, etc., are incorporated into 90-day studies, de-
pending on the information needed for an individual
chemical. The additional toxicity end points are evalu-
ated in core animals when feasible, and extra groups of
animals may be incorporated into the study.
Two-Year Toxicity/Carcinogenicity Studies
The objectives oftoxicity/carcinogenicity studies are
tocharacterizelong-termtoxiceffectsandtoidentifythe
carcinogenic potential of chemicals in laboratory ani-
mals. These studies are usuallyperformed atthree dose
levels, plus control groups of Fischer 344 rats and
B6C3F1 mice ofboth sexes. Additional characterization
of chronic toxicity is achieved by studying 10 animals
fromeach ofthedosegroupsthatarekilled at 15months
(Table 10).
The chemical is administered for 2 years; 10 in feed
and water studies, the chemical is available 24 hr per
day, 7 days per week; for oral intubation and dermal
studies the chemical is given or applied daily five times
per week; inhalation exposures are given 6 hr per day 5
days per week. Individual animal body weights are
recorded weekly for the first 13 weeks and at 4-week
intervals thereafter. If significant morbidity or mor-
tality occur during the study, the observation and wei-
ghing frequency may be increased. If considerable un-
anticipated deaths occur, the study may have to be
modified or restarted. All animals that die or are killed
during and at the end ofthe experiment receive a com-
plete necropsy and microscopic examination of all
tissues.
At65weeksintothe study, upto 10animals/dose/sex/
speciesarekilledand specifictoxicologicparameters are
determined. Generally, these include specific organ
weight, hematology determinations, and complete
necropsy and histopathologic evaluation oftissues from
all animals in all dose groups plus control groups. Other
toxicity end points are incorporated, depending on the
chemical being evaluated. Information from these
15-month evaluations allows better planning and more
astutepathologyexaminations; forexample, morehisto-
pathologic sections can be taken for obvious target or-
gans. Remaining animals that are exposed for 2 years
are killed 1 week after cessation of treatment. A com-
pletenecropsyandahistopathologicevaluation(Table9)
Table 10. Two-year toxicology and carcinogenesis studies.
Exposure
Parameter Animals Species Sex levels Totals
Exposure
groups 60 2 2 3 720
Controls 60 2 2 1 240
Sentinel 15 2 2 60
Total 1020
Exposure duration 104 weeks
Interim evaluations Week 65
Toxicity end points Chronic toxicity, carcinogenicity
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are routinely conducted on all animals from all dose
groups and controls including the 65-week groups.
Conclusions
Thispapergivesabriefoverviewofthetoxicologyand
long-term carcinogenesis studies designed and con-
ducted bythe NTP. The coredesign interms ofnumber
of dose groups and group sizes for 14-day and 90-day
studies arenotsignificantlydifferentfromtheonesused
in the past (32). The major difference in the prechronic
studies perforned inthepastinvolve theprimaryobjec-
tiveofestablishingdosestobeusedinsubsequent carci-
nogenesis studies. The objectives of90-day studies are
generally 2-fold: to more completely characterize toxic-
ity ofthe chemicals (stand-alone studies) and to develop
data of a wide scope to better design toxicity/
carcinogenicity studies. The objectives of chronic
toxicity/carcinogenicity are to evaluate long-term toxic-
ity as well as the carcinogenic potential ofchemicals. In
addition, chronicstudies areconductedtoevaluatedose-
response relationships. An interim evaluation, usually
atweek65, isincluded to evaluate long-term and/orlate
appearingtoxic effectsofthechemicals intheabsence of
oldagelesionsthatarenormallyfound at 104weeksthat
can mask toxic lesions (37).
The NTP studies are designed to exploit the unique-
ness ofthe chemicalbeingevaluated; therefore, flexibil-
ity is important in the protocol development of each
study. Toaccomplishthis, NTPusesamulti-disciplinary
team ofexperts within its organization who review and
evaluate the appropriateness of toxicology procedures
for each study design. As scientific advances in toxicol-
ogy are discovered that are directly relevant to these
studies, newer techniques will be adopted where
appropriate.
TheauthorsgreatlyappreciatetheencouragementgivenbyEugene
McConnell for preparation ofthis manuscript and Gary Boorman and
RobertMaronpotfortheirvaluable critiqueandin-housepeerreview.
Also, weacknowledge thecontributionoftheentireNTPstaffwhohas
participated in the development/evolution ofpresent NTP strategies
to evaluate the toxicity and carcinogenicity ofchemicals.
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